Auto-generated from public data. Not the firm's stated position.
TruVenturo appears to focus on early-stage investments across fintech, marketplace, and proptech sectors, with a disclosed check size of €1.5M, €3.0M. Recent portfolio companies suggest an interest in consumer-facing digital platforms spanning travel, leisure, and emerging biotech verticals. The firm's activity in pre-seed and seed stages indicates a strategy targeting foundational growth phases in these market segments.
Generated 2 Oct 2026 from disclosed sectors, stages, and portfolio companies. Firms can update this by emailing [email protected].
Auto-detected from TruVenturo's website.
Manages day-to-day operations, strategic deal sourcing, and fundraising, formerly at Latham & Watkins.
CEO and founder with over a decade of experience, responsible for investment strategy and company building activities.
Over a decade of experience in life sciences venture building and venture capital, spearheading neurotechnology initiatives.
Serial entrepreneur and company builder with passion for health and biotech, co-founder of Apollo Health Ventures.
Focus and check size from the firm's website. Website reachable as of Oct 2026.
A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.